EUVIMEDEUVIMED entdecken
Crossref

Matrix‐Metalloproteinase Inhibitory Study of Novel Tetrahydroisoquinoline‐4‐carboxylates: Design, Synthesis, and Molecular Docking Studies

Nayak Devappa Satyanarayan, Manjunatha Kammathalli Siddappa, Abdul Rahman, Nippu Belur Ningegowda, Ankith Sherapura, B M Siddesh, B T Prabhakar

Chemistry & Biodiversity · 2023

DOI: 10.1002/cbdv.202201152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Nayak Devappa Satyanarayan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Kuvempu University, Post Graduate Center, Kadur, Chikkamagaluru, Karnataka 577548, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Tetrahydroisoquinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Kuvempu University, IISc Bangalore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The design, molecular docking, synthesis and structure‐activity relationship (SAR) of a series of novel methyl 1‐oxo‐2‐(propan‐2‐yl)‐3‐(pyridin‐3‐yl)‐1,2,3,4‐tetrahydroisoquinoline‐4‐carboxylates, were investigated for antiproliferative and cytotoxic studies by screening against cancer cell lines of different origin by MTT, LDH and Trypan Blue Assay. Irrespective of cell lines, among the synthesized nonpeptido‐mimetic analogs 5a – e , 5c has executed potent bio‐potency with IC 50 value of 7.00 to 7.21 μM, which further expressed in‐vivo anti‐tumor activity against murine T‐cell lymphoma cell lines (Daltons Lymphoma‐DLA) by regressing tumor growth. The formation of neovessels from the vasculogenesis was diminished reflecting the antitumor activity. The neovessel formation is directly relied on expression of matrix meteloproteases (MMP's) level which was drastically reduced by 5c treatment as evaluated by immonoblot assays. This is further supported by in‐silico ADMET studies performed by ACD I‐Lab 2.0 were in agreement with Lipinski rule of five. Reporting results were assessed as a positive parameter for further validation of the compound for therapeutic potential of cancer by 5c for preclinical studies in near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsTetrahydroisoquinolinesAnimalsMiceMolecular StructureMolecular Docking SimulationCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorStructure-Activity RelationshipMetalloproteasesDrug DesignProtein Kinase Inhibitors

Stichwörter der Autor:innen

EGFRVEGFR2angiogenesisclioquinolcytotoxicitytyrosine kinase receptor

Substanzen

Antineoplastic AgentsTetrahydroisoquinolinesMetalloproteasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Kuvempu University, Post Graduate Center, Kadur, Chikkamagaluru, Karnataka 577548, India.
  • Molecular Biomedicine Laboratory, Post Graduate Department of Studies and Research in Biotechnology, Sahyadri Science College (Autonomous), Kuvempu University, Shivamogga, Karnataka, 577203, India.

Förderung

  • Kuvempu University
  • IISc Bangalore

Zitieren

APA

Devappa Satyanarayan, N., Kammathalli Siddappa, M., Rahman, A., Belur Ningegowda, N., Sherapura, A., Siddesh, B. M., & Prabhakar, B. T. (2023). Matrix‐Metalloproteinase Inhibitory Study of Novel Tetrahydroisoquinoline‐4‐carboxylates: Design, Synthesis, and Molecular Docking Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202201152

Vancouver

Devappa Satyanarayan N, Kammathalli Siddappa M, Rahman A, Belur Ningegowda N, Sherapura A, Siddesh BM, et al. Matrix‐Metalloproteinase Inhibitory Study of Novel Tetrahydroisoquinoline‐4‐carboxylates: Design, Synthesis, and Molecular Docking Studies. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202201152

BibTeX
@article{DevappaSatyanarayan2023,
  author = {Devappa Satyanarayan, Nayak and Kammathalli Siddappa, Manjunatha and Rahman, Abdul and Belur Ningegowda, Nippu and Sherapura, Ankith and Siddesh, B M and Prabhakar, B T},
  title = {Matrix‐Metalloproteinase Inhibitory Study of Novel Tetrahydroisoquinoline‐4‐carboxylates: Design, Synthesis, and Molecular Docking Studies},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  doi = {10.1002/cbdv.202201152}
}
Kostenlos starten →